Loading…
Parkin modulates gene expression in control and ceramide-treated PC12 cells
Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether th...
Saved in:
Published in: | Molecular biology reports 2006-03, Vol.33 (1), p.13-32 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903 |
---|---|
cites | cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903 |
container_end_page | 32 |
container_issue | 1 |
container_start_page | 13 |
container_title | Molecular biology reports |
container_volume | 33 |
creator | Unschuld, P G Dächsel, J Darios, F Kohlmann, A Casademunt, E Lehmann-Horn, K Dichgans, M Ruberg, M Brice, A Gasser, T Lücking, C B |
description | Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner. |
doi_str_mv | 10.1007/s11033-005-3961-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20481619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2111128881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</originalsourceid><addsrcrecordid>eNpdkE1LxDAQhoMouq7-AC9SPHiLZpqPNkdZ_MIF96DnkLYT6do2a9KC_nuz7ILgaWDmeYeXh5ALYDfAWHEbARjnlDFJuVZA5QGZgSw4FbooD8mMcQZUlBJOyGmMa8aYgEIekxNQiisNYkZeVjZ8tkPW-2bq7Igx-8ABM_zeBIyx9UOWjrUfxuC7zA5NVmOwfdsgHQMmvslWC8jTtuviGTlytot4vp9z8v5w_7Z4osvXx-fF3ZLWXBYjFVZaIZnTUrDSaa6k5qkp5javK6F4ZVVZKls6lad15bBBVzgEyHPIG834nFzv_m6C_5owjqZv47aBHdBP0eRMlKBAJ_DqH7j2UxhSN1MIkdRJLhIEO6gOPsaAzmxC29vwY4CZrWaz02ySZrPVbGTKXO4fT1WPzV9i75X_AoE5dkE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>744033534</pqid></control><display><type>article</type><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><source>Springer Link</source><creator>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</creator><creatorcontrib>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</creatorcontrib><description>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-005-3961-5</identifier><identifier>PMID: 16636914</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Age ; Animals ; Apoptosis ; Basal ganglia ; Cell culture ; Cell death ; Central nervous system diseases ; Ceramide ; Ceramides - pharmacology ; DNA microarrays ; Dopamine receptors ; Gadd45A protein ; Gene expression ; Gene Expression Regulation - drug effects ; Humans ; Movement disorders ; Neurodegeneration ; Oligonucleotides ; Parkin protein ; PC12 Cells ; Pheochromocytoma cells ; Rats ; RNA, Messenger - genetics ; Sphingolipid ceramide ; Transcription, Genetic - drug effects ; Transcription, Genetic - genetics ; Ubiquitin-Protein Ligases - genetics ; Ubiquitin-Protein Ligases - metabolism</subject><ispartof>Molecular biology reports, 2006-03, Vol.33 (1), p.13-32</ispartof><rights>Springer 2006.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</citedby><cites>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16636914$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Unschuld, P G</creatorcontrib><creatorcontrib>Dächsel, J</creatorcontrib><creatorcontrib>Darios, F</creatorcontrib><creatorcontrib>Kohlmann, A</creatorcontrib><creatorcontrib>Casademunt, E</creatorcontrib><creatorcontrib>Lehmann-Horn, K</creatorcontrib><creatorcontrib>Dichgans, M</creatorcontrib><creatorcontrib>Ruberg, M</creatorcontrib><creatorcontrib>Brice, A</creatorcontrib><creatorcontrib>Gasser, T</creatorcontrib><creatorcontrib>Lücking, C B</creatorcontrib><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><description>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</description><subject>Age</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Basal ganglia</subject><subject>Cell culture</subject><subject>Cell death</subject><subject>Central nervous system diseases</subject><subject>Ceramide</subject><subject>Ceramides - pharmacology</subject><subject>DNA microarrays</subject><subject>Dopamine receptors</subject><subject>Gadd45A protein</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Movement disorders</subject><subject>Neurodegeneration</subject><subject>Oligonucleotides</subject><subject>Parkin protein</subject><subject>PC12 Cells</subject><subject>Pheochromocytoma cells</subject><subject>Rats</subject><subject>RNA, Messenger - genetics</subject><subject>Sphingolipid ceramide</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transcription, Genetic - genetics</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><subject>Ubiquitin-Protein Ligases - metabolism</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpdkE1LxDAQhoMouq7-AC9SPHiLZpqPNkdZ_MIF96DnkLYT6do2a9KC_nuz7ILgaWDmeYeXh5ALYDfAWHEbARjnlDFJuVZA5QGZgSw4FbooD8mMcQZUlBJOyGmMa8aYgEIekxNQiisNYkZeVjZ8tkPW-2bq7Igx-8ABM_zeBIyx9UOWjrUfxuC7zA5NVmOwfdsgHQMmvslWC8jTtuviGTlytot4vp9z8v5w_7Z4osvXx-fF3ZLWXBYjFVZaIZnTUrDSaa6k5qkp5javK6F4ZVVZKls6lad15bBBVzgEyHPIG834nFzv_m6C_5owjqZv47aBHdBP0eRMlKBAJ_DqH7j2UxhSN1MIkdRJLhIEO6gOPsaAzmxC29vwY4CZrWaz02ySZrPVbGTKXO4fT1WPzV9i75X_AoE5dkE</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Unschuld, P G</creator><creator>Dächsel, J</creator><creator>Darios, F</creator><creator>Kohlmann, A</creator><creator>Casademunt, E</creator><creator>Lehmann-Horn, K</creator><creator>Dichgans, M</creator><creator>Ruberg, M</creator><creator>Brice, A</creator><creator>Gasser, T</creator><creator>Lücking, C B</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20060301</creationdate><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><author>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Age</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Basal ganglia</topic><topic>Cell culture</topic><topic>Cell death</topic><topic>Central nervous system diseases</topic><topic>Ceramide</topic><topic>Ceramides - pharmacology</topic><topic>DNA microarrays</topic><topic>Dopamine receptors</topic><topic>Gadd45A protein</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Movement disorders</topic><topic>Neurodegeneration</topic><topic>Oligonucleotides</topic><topic>Parkin protein</topic><topic>PC12 Cells</topic><topic>Pheochromocytoma cells</topic><topic>Rats</topic><topic>RNA, Messenger - genetics</topic><topic>Sphingolipid ceramide</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transcription, Genetic - genetics</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><topic>Ubiquitin-Protein Ligases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Unschuld, P G</creatorcontrib><creatorcontrib>Dächsel, J</creatorcontrib><creatorcontrib>Darios, F</creatorcontrib><creatorcontrib>Kohlmann, A</creatorcontrib><creatorcontrib>Casademunt, E</creatorcontrib><creatorcontrib>Lehmann-Horn, K</creatorcontrib><creatorcontrib>Dichgans, M</creatorcontrib><creatorcontrib>Ruberg, M</creatorcontrib><creatorcontrib>Brice, A</creatorcontrib><creatorcontrib>Gasser, T</creatorcontrib><creatorcontrib>Lücking, C B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Unschuld, P G</au><au>Dächsel, J</au><au>Darios, F</au><au>Kohlmann, A</au><au>Casademunt, E</au><au>Lehmann-Horn, K</au><au>Dichgans, M</au><au>Ruberg, M</au><au>Brice, A</au><au>Gasser, T</au><au>Lücking, C B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parkin modulates gene expression in control and ceramide-treated PC12 cells</atitle><jtitle>Molecular biology reports</jtitle><addtitle>Mol Biol Rep</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>33</volume><issue>1</issue><spage>13</spage><epage>32</epage><pages>13-32</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>16636914</pmid><doi>10.1007/s11033-005-3961-5</doi><tpages>20</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-4851 |
ispartof | Molecular biology reports, 2006-03, Vol.33 (1), p.13-32 |
issn | 0301-4851 1573-4978 |
language | eng |
recordid | cdi_proquest_miscellaneous_20481619 |
source | Springer Link |
subjects | Age Animals Apoptosis Basal ganglia Cell culture Cell death Central nervous system diseases Ceramide Ceramides - pharmacology DNA microarrays Dopamine receptors Gadd45A protein Gene expression Gene Expression Regulation - drug effects Humans Movement disorders Neurodegeneration Oligonucleotides Parkin protein PC12 Cells Pheochromocytoma cells Rats RNA, Messenger - genetics Sphingolipid ceramide Transcription, Genetic - drug effects Transcription, Genetic - genetics Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism |
title | Parkin modulates gene expression in control and ceramide-treated PC12 cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A02%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parkin%20modulates%20gene%20expression%20in%20control%20and%20ceramide-treated%20PC12%20cells&rft.jtitle=Molecular%20biology%20reports&rft.au=Unschuld,%20P%20G&rft.date=2006-03-01&rft.volume=33&rft.issue=1&rft.spage=13&rft.epage=32&rft.pages=13-32&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-005-3961-5&rft_dat=%3Cproquest_cross%3E2111128881%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=744033534&rft_id=info:pmid/16636914&rfr_iscdi=true |